HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.

AbstractOBJECTIVE:
To construct a grading score that predicts neurologic function 1 year after diagnosis of anti-NMDA receptor (NMDAR) encephalitis.
METHODS:
Three hundred eighty-two patients with detailed information and functional status at 1 year were studied. Factors associated with poor status (defined as modified Rankin Scale score ≥3) were identified and incorporated into a multivariate logistic regression model. This model was used to develop a 5-point prediction score, termed the anti-NMDAR Encephalitis One-Year Functional Status (NEOS) score.
RESULTS:
Intensive care unit admission (p < 0.001), treatment delay >4 weeks (p = 0.012), lack of clinical improvement within 4 weeks (p < 0.001), movement disorder (p = 0.001), central hypoventilation (p < 0.001), elevated CSF white blood cell count (p < 0.001), elevated CSF protein level (p = 0.027), and abnormal MRI (p = 0.002) were associated with 1-year functional status in univariate analysis. Intensive care unit admission, treatment delay >4 weeks, lack of clinical improvement within 4 weeks, abnormal MRI, and CSF white blood cell count >20 cells/μL were independent predictors for outcome in multivariate regression modeling. These 5 variables were assigned 1 point each to create the NEOS score. NEOS score strongly associated with the probability of poor functional status at 1 year (3% for 0 or 1 point to 69% for 4 or 5 points, p < 0.001).
CONCLUSIONS:
The NEOS score accurately predicts 1-year functional status in patients with anti-NMDAR encephalitis. This score could help estimate the clinical course following diagnosis and may aid in identifying patients who could benefit from novel therapies.
AuthorsRamani Balu, Lindsey McCracken, Eric Lancaster, Francesc Graus, Josep Dalmau, Maarten J Titulaer
JournalNeurology (Neurology) Vol. 92 Issue 3 Pg. e244-e252 (01 15 2019) ISSN: 1526-632X [Electronic] United States
PMID30578370 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis (diagnosis, genetics, physiopathology)
  • Child
  • Child, Preschool
  • Electroencephalography
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Logistic Models
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Movement Disorders (etiology)
  • Neurologic Examination
  • Predictive Value of Tests
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: